Search alternatives:
teer decrease » greater decrease (Expand Search)
ppm decrease » _ decrease (Expand Search), nn decrease (Expand Search), pa decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » greater decrease (Expand Search)
ppm decrease » _ decrease (Expand Search), nn decrease (Expand Search), pa decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
26101
<i>vang-1</i> shows reproduction- and aging-related defects.
Published 2012“…<b>(B–C) </b><b><i>ok1142</i></b><b> and </b><b><i>tm1422</i></b><b> show decreased lipofuscin accumulation five and ten days after hatching.…”
-
26102
Myelomonocytic expansion in blood, bone marrow, and spleen of young TAK1<sup>ΔM</sup> mice.
Published 2013“…<p>(<b>A</b>) Increased neutrophils and monocytes in young TAK1<sup>ΔM</sup> mice. Mean (± SEM) peripheral white blood cell differential counts from 6- to 8-week-old female TAK1<sup>F/+</sup> (n = 7) and TAK1<sup>ΔM</sup> (n = 10) mice show dramatic increases in neutrophils (<i>P</i><0.0001) and monocytes (<i>P</i> = 0.0083) and decreases in lymphocytes (<i>P</i><0.0001). …”
-
26103
Distribution of estimated parameters by the three approaches.
Published 2022“…The dual optimization approach improved the estimation precision by decreasing the standard deviation of the PDF and moving the mean of the PDFs closer to the true values. …”
-
26104
DataSheet1_Effects of pharmacogenomics-guided treatment on medication adherence and the antidepressant switching rate in major depressive disorder.docx
Published 2024“…Background<p>In the treatment of depression, medication plays a crucial role. However, insufficient patient adherence to medication often results in unsatisfactory treatment outcomes, increasing both the recurrence and rehospitalization rates of depression, and consequently imposing a greater economic burden on the healthcare system.…”
-
26105
Morphine withdrawal-induced CREB activation in the PVN is dependent on α<sub>1</sub>-adrenoceptor stimulation.
Published 2013“…Data correspond to mean ± SEM. Post hoc analysis revealed a significant decrease in pCREB immunoreactivity in prazosin-pretreated rats. …”
-
26106
Characterization of phenotypically unique accessions.
Published 2025“…The map was created with data from Natural Earth via the R package <i><i>rnaturalearth</i></i> [<a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003536#pbio.3003536.ref030" target="_blank">30</a>] (basemap shapefile: <a href="https://www.naturalearthdata.com/downloads/50m-cultural-vectors/" target="_blank">https://www.naturalearthdata.com/downloads/50m-cultural-vectors/</a>). …”
-
26107
Increased Uptake of CHF5633 by Alveolar Monocyte.
Published 2013“…SP-C in CHF5633 input sample was given a value of 1. SP-C relative to Sat PC was decreased in supernatant or smaller form surfactant to half of that in input sample and BALF pellet samples. …”
-
26108
Coarse-grained model leads to collective behavior.
Published 2017“…The peak in susceptibility becomes higher the larger the number of cells, and NN distances decrease accordingly. Profiles in the inset were smoothed with a moving average filter spanning ten points. …”
-
26109
-
26110
-
26111
-
26112
-
26113
-
26114
-
26115
-
26116
-
26117
-
26118
-
26119
Data_Sheet_1_SWL-1 Reverses Fluconazole Resistance in Candida albicans by Regulating the Glycolytic Pathway.doc
Published 2020“…In this study, we show that SWL-1 reverses resistance to fluconazole in C. albicans when delivered in combination, with a sharp decrease in the IC<sub>50</sub> of fluconazole from >200 to 3.74 ± 0.25 μg/ml, and also reverses the fluconazole resistance of C. albicans in vitro, with IC<sub>50</sub> from >200 to 5.3 ± 0.3 μg/ml. …”
-
26120
An Integrated Disease/Pharmacokinetic/Pharmacodynamic Model Suggests Improved Interleukin-21 Regimens Validated Prospectively for Mouse Solid Cancers
Published 2011“…Simulations of the verified model surfaced important therapeutic insights: (1) Fractionating the standard daily regimen (50 µg/dose) into a twice daily schedule (25 µg/dose) is advantageous, yielding a significantly lower tumor mass (45% decrease); (2) A low-dose (12 µg/day) regimen exerts a response similar to that obtained under the 50 µg/day treatment, suggestive of an equally efficacious dose with potentially reduced toxicity. …”